Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)

Bahaa Abu-Raya, Giovanni Battista Migliori, Miguel O'Ryan, Kathryn Edwards, Antoni Torres, Jan-Willem Alffenaar, Anne-Grete Märtson, Rosella Centis, Lia D'Ambrosio, Katie Flanagan, Ivan Hung, Fulvio Lauretani, Chi Chi Leung, Elke Leuridan, Kirsten Maertens, Marcello Giuseppe Maggio, Simon Nadel, Niel Hens, Hubert Niesters, Albert OsterhausEmanuele Pontali, Nicola Principi, Denise Rossato Silva, Saad Omer, Antonio Spanevello, Nicola Sverzellati, Tina Tan, Juan Pablo Torres-Torreti, Dina Visca, Susanna Esposito

Research output: Contribution to journalReview articlepeer-review

Abstract

Coronavirus disease 2019 (COVID-19) is a rapidly evolving, highly transmissible, and potentially lethal pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). As of June 11 2020, more than 7,000,000 COVID-19 cases have been reported worldwide, and more than 400,000 patients have died, affecting at least 188 countries. While literature on the disease is rapidly accumulating, an integrated, multinational perspective on clinical manifestations, immunological effects, diagnosis, prevention, and treatment of COVID-19 can be of global benefit. We aimed to synthesize the most relevant literature and experiences in different parts of the world through our global consortium of experts to provide a consensus-based document at this early stage of the pandemic.

Original languageEnglish
Pages (from-to)572485
JournalFrontiers in Medicine
Volume7
DOIs
Publication statusPublished - 2020

Fingerprint Dive into the research topics of 'Coronavirus Disease-19: An Interim Evidence Synthesis of the World Association for Infectious Diseases and Immunological Disorders (Waidid)'. Together they form a unique fingerprint.

Cite this